GNMK Share Price

Open 11.30 Change Price %
High 11.51 1 Day -0.08 -0.70
Low 11.17 1 Week -0.61 -5.13
Close 11.27 1 Month 0.27 2.45
Volume 206930 1 Year 3.59 46.74
52 Week High 13.29
52 Week Low 0.00
GNMK Important Levels
Resistance 2 11.59
Resistance 1 11.46
Pivot 11.32
Support 1 11.08
Support 2 10.95
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

GenMark Diagnostics, Inc. (NASDAQ: GNMK)

GNMK Technical Analysis 1.5
As on 2nd Dec 2016 GNMK Share Price closed @ 11.27 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.24 & Sell for SHORT-TERM with Stoploss of 11.79 we also expect STOCK to react on Following IMPORTANT LEVELS.
GNMK Target for December
1st Target up-side 13.2
2nd Target up-side 14.31
3rd Target up-side 15.42
1st Target down-side 10.04
2nd Target down-side 8.93
3rd Target down-side 7.82
GNMK Other Details
Segment EQ
Market Capital 273291424.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.genmarkdx.com
GNMK Address
GNMK
5964 La Place Court
Carlsbad, CA 92008
United States
Phone: 760-448-4300
Fax: 760-448-4301
GNMK Latest News
Interactive Technical Analysis Chart GenMark Diagnostics, Inc. ( GNMK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GenMark Diagnostics, Inc.
GNMK Business Profile
GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology. The Company�s electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA), and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its eSensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.